Treatment of livedoid vasculopathy with sulodexide: A prospective study of 35 cases
Our study demonstrates that sulodexide monotherapy is a clinically effective and well-tolerated therapeutic option for patients with LV. Adjunctive JAK inhibitor therapy, when clinically indicated, may yield superior therapeutic outcomes.
Authors
- Fazhan Ban
- QingYang Li
- Erle Dang
- Daopei Zou
- Wenjun Liao
- Lei Wang
- Gang Wang
- Yuan Yuan
- Mengyu Zhang
- Xin Wen
Institutions
- Xijing Hospital (CN)
- Air Force Medical University (CN)
Publication Details
- Journal
- JDDG Journal der Deutschen Dermatologischen Gesellschaft
- Published
- 2026-01-02
- DOI
- https://doi.org/10.1111/ddg.15965
- Primary Topic
- Systemic Lupus Erythematosus Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00